Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Oncoustics Oncoustics initiates FDA study of the OnX Liver Assessment Solution at clinical sites across the US and Canada marking a milesto ...

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

Alcohol-related liver disease has more than doubled in the U.S. over the last 20 years.

Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, ...

Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, ...

Metabolic dysfunction-associated steatotic liver disease is the leading driver of compensated advanced liver disease in the US.